 - Subjects using one of the following topical drugs for the treatment of psoriasis within two 2 weeks prior to study drug administration: - WHO group I-II corticosteroids - Topical retinoids - Vitamin D-analogues - Topical immunomodulators e.g. macrolides - Anthracen derivatives - Tar - Salicylic acid - UVB therapy 